(Q46484874)

English

Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study

scientific article published in July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

lupus nephritis

1 reference

based on heuristic

inferred from title

author name string

H Y Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

T G Cui

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

F F Hou

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

Z H Ni

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

X M Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

F M Lu

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

F F Xu

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

X Q Yu

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

F S Zhang

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

X Z Zhao

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

M H Zhao

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

G B Wang

12

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

J Q Qian

13

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

G Y Cai

14

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

T Y Zhu

15

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

Y H Wang

16

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

Z P Jiang

17

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

Y N Li

18

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

C L Mei

19

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

W Z Zou

20

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

China Leflunomide Lupus Nephritis Study Group

21

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

17

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

638-644

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

Cyclophosphamide in lupus nephritis

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

Leflunomide: mode of action in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

Leflunomide-mediated suppression of antiviral antibody and Tcell responses: differential restoration by uridine

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study

1 reference

https://api.crossref.org/works/10.1177%2F0961203308089408

21 January 2018

Identifiers

10.1177/0961203308089408

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18625636

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46484874&oldid=2113452365"